General Wellness

Jul 26

Senolytic Therapy for Post-Menopausal Bone & Metabolic Health: The D+Q Breakthrough

By Dr. Emily Hartman General Wellness

Takeaways Senolytics clear “zombie” cells, boosting bone formation and metabolic markers in high–senescence post-menopausal women. Biomarker screening with p16INK4a helps clinicians target those most likely to benefit from intermittent D + Q dosing.…

Dec 10

Love0

Vitamin D Supplementation: Enhancing Immune Function and Bone Health

By Damian General Wellness

Understanding the Power of Vitamin D for Health Vitamin D plays a critical role in overall health, supporting not only bones but also the immune system. This essential vitamin helps the body in…

Jul 22

Love0

Customized Wellness Plans for Corporate Wellness Programs

By Alex Morgan (Guest Author) General Wellness

Boosting Employee Health and Productivity In today's competitive business environment, employee well-being is paramount. Customized wellness plans have emerged as a powerful tool to enhance employee health and productivity. This article delves into…

Medical Weight Loss

GPCR-Targeted Obesity Therapies: The Next Frontier Beyond GLP-1 Drugs

Takeaways Emerging GPCR-targeted therapies could offer oral, appetite-modifying weight-loss options with fewer GI side effects. GSBR-1290 shows real human efficacy (~5–7% weight loss) and convenience, while BRP highlights non-incretin, central-acting alternatives in preclinical…

Daxxify’s Role in Hormone-Sensitive Aesthetic Care

Testosterone Replacement Therapy

Daxxify’s Emerging Role in Hormone-Sensitive Aesthetic Medicine

Takeaways Daxxify offers significantly longer-lasting results (6–9 months) compared to traditional neuromodulators, making it especially appealing for patients with hormonal fluctuations. No peer-reviewed research yet exists linking Daxxify’s use to stabilizing estrogen-influenced dermal changes,…

Designer Estrogens 2.0: Tissue-Selective HRT Without Cancer Risk

Testosterone Replacement Therapy

Designer Estrogens 2.0: A New Era in Tissue-Selective Hormone Therapy

Takeaways Designer Estrogens 2.0 offer targeted bone and cognitive benefits while minimizing breast and uterine cancer risks. The 2025 UCSF Phase II trial shows improved bone density and memory with no evidence of…

CHECK OUT OUR BLOG HERE